维普期刊资源整合服务平台（V6.5）

58篇 您的检索式：作者名="Tutt M"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-con- cept trlal显示文摘	Tutt A Robson M C arber JE	2010	Lancet2010，376，9737：	1
2	The interaction of methylene-blue,azure-B,and thionine with DNA-formation of complexes with polynucleotides and mononucleotides as model system显示文摘	Tutte E Kelly J M	1995	Biopolymers1995，35，5：	1
3	Oral poly(ADP-ribose) polymer- ase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial 显示文摘	Tutt A Robson M Garber JE	2010	Lancet2010，376，9737：	1
4	Oral poly(ADP-ribose) poly- merase inhibitor olaparib in patients with BRCA1 or BRCA2 muta- tions and advanced breast cancer: a proof-of-concept trial 显示文摘	Tutt A Robson M Garber JE	2010	Lan- cet2010，376，9737：	1
5	Pharmacologi-cal management of hemodynamic complications fol-lowing spinal cord injury 显示文摘	McMahon D Tutt M Cook AM d al	2009	Orthopedics2009，32，5：	1
6	Oral poly(ADP-ri- bose) polymerase inhibitor olaparib in patients with BRCAI or BRCA2 mutations and advanced breast can- cer: a proof-of-concept trial显示文摘	Tutt A Robson M Garber JE	2010	Lancet2010，376，9737：	1
7	Oral poly ( ADP-ribose ) poly- merase inhibitor olaparib in patients with BRCA1 or BRCA2 muta- tions and advanced breast cancer: a proof-of-concept trial 显示文摘	Tutt A Robson M Garber JE	2010	Lancet2010，376，9737：	1
8	The translational pharmacology of a novel, potent, and selective nonsteroidal proges- terone receptor antagonist, 2-显示文摘	De Giorgio-Miller A Bungay P Tutt M	2008	J Pharmacol Exp Ther2008，327，1：	1
9	Oral poly(ADP-ribose)pol- ymerase inhibitor olaparib in patients with BRCA1 or BRCA2 muta- tions and advanced breast caneer:a proof of concept trial显示文摘	Tutt A Robson M Garber JE et ai	2010	Lan- cet2010，376，9737：	1
10	Oral poly (ADP-ribose)polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer:a proof-of-concept trial显示文摘	Tutt A Robson M Garber JE		0，，：	1
11	'Phase Ⅱ trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer'显示文摘	Tutt A Robson M Garber JE	2009	J Clin Oncol2009，27，：	1
12	Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCAI or BRCA2 mutations and advanced breast cancer :a proof-of-concept trial 显示文摘	Tutt A Robson M Garber JE	2010	Lancet2010，376，9737：	1
13	Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer:a proofof-concept trial显示文摘	Tutt A Robson M Garber JE		0，，9737：	1
14	Oral poly (ADP- ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof- of- concept trial显示文摘	TUTT A ROBSON M GARBER JE et ol	2010	Lallo_t2010，376，9737：	1
15	Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer:a proof-of-concept trial显示文摘	Tutt A Robson M Garber JE		0，，9737：	1
16	Optical limiting with C60 in polymethylethacrylate显示文摘	Kost A Tutt L Klein M B		0，，：	1
17	Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer:a proof-of-concept trial显示文摘	Tutt A Robson M Garber JE	2010	Lancet2010，376，9737：	1
18	Phase Ⅱ trial of the oral PARP inhibitor olaparib in BRCA -deficient advanced breast cancer显示文摘	Tutt A Robson M Garber JE	2009	J Clin Oncol (Meeting Abstracts)2009，18，：	1
19	Optical limiting with opt C60 in polymethyl methacrylate 显示文摘	Kost A Tutt L Klein M B	1993	Opt Lett1993，18，5：	1
20	Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial 显示文摘	Tutt A Robson M Garber JE	2010	Lancet2010，376，9737：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示